Gujarat Kidney And Super Speciality Limited (NSE:GKSL)
India
· Delayed Price · Currency is INR 115.44
+3.00 (2.67%)
At close: Apr 27, 2026
NSE:GKSL Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Revenue | 612.17 | 402.42 | 47.74 | - | 7.86 | 11.03 |
| Revenue Growth (YoY) | 1182.22% | 742.89% | - | - | -28.71% | - |
| Cost of Revenue | 181.94 | 129.15 | 14.32 | - | 0.48 | 0.66 |
| Gross Profit | 430.24 | 273.28 | 33.42 | - | 7.38 | 10.36 |
| Selling, General & Admin | 4.32 | 4.32 | 0.61 | - | 0.15 | 1.2 |
| Other Operating Expenses | 193.33 | 103.49 | 13.3 | 0.04 | 0.05 | 1.32 |
| Operating Expenses | 238.57 | 140.71 | 17.11 | 0.04 | 5.94 | 9.26 |
| Operating Income | 191.67 | 132.57 | 16.32 | -0.04 | 1.44 | 1.1 |
| Interest Expense | -12.15 | -6.37 | -0.64 | -0.02 | -0.09 | - |
| Interest & Investment Income | 1.15 | 1.15 | 0.02 | - | - | - |
| Other Non Operating Income (Expenses) | 0.47 | -0.09 | -0.03 | - | - | - |
| EBT Excluding Unusual Items | 181.13 | 127.26 | 15.67 | -0.06 | 1.35 | 1.1 |
| Gain (Loss) on Sale of Assets | - | - | 7.02 | - | - | - |
| Other Unusual Items | 0.4 | 0.4 | - | - | - | - |
| Pretax Income | 181.53 | 127.65 | 22.68 | -0.06 | 1.35 | 1.1 |
| Income Tax Expense | 48.34 | 32.66 | 5.54 | -0 | 0.36 | 0.28 |
| Earnings From Continuing Operations | 133.18 | 94.99 | 17.14 | -0.06 | 0.98 | 0.82 |
| Minority Interest in Earnings | -15.86 | -0.86 | - | - | - | - |
| Net Income | 117.33 | 94.13 | 17.14 | -0.06 | 0.98 | 0.82 |
| Net Income to Common | 117.33 | 94.13 | 17.14 | -0.06 | 0.98 | 0.82 |
| Net Income Growth | 584.52% | 449.19% | - | - | 19.50% | - |
| Shares Outstanding (Basic) | 58 | 51 | 35 | 35 | 35 | 35 |
| Shares Outstanding (Diluted) | 58 | 51 | 35 | 35 | 35 | 35 |
| Shares Change (YoY) | 64.96% | 45.75% | - | - | - | - |
| EPS (Basic) | 2.03 | 1.85 | 0.49 | -0.00 | 0.03 | 0.02 |
| EPS (Diluted) | 2.03 | 1.85 | 0.49 | -0.00 | 0.03 | 0.02 |
| EPS Growth | 314.97% | 276.81% | - | - | 19.50% | - |
| Free Cash Flow | - | 24.92 | 12.13 | 0 | 0.02 | -0.99 |
| Free Cash Flow Per Share | - | 0.49 | 0.35 | - | 0.00 | -0.03 |
| Gross Margin | 70.28% | 67.91% | 70.00% | - | 93.89% | 93.98% |
| Operating Margin | 31.31% | 32.94% | 34.17% | - | 18.32% | 9.99% |
| Profit Margin | 19.17% | 23.39% | 35.90% | - | 12.53% | 7.47% |
| Free Cash Flow Margin | - | 6.19% | 25.40% | - | 0.30% | -8.98% |
| EBITDA | 220.49 | 160.12 | 19.14 | 5.7 | 7.18 | 7.84 |
| EBITDA Margin | 36.02% | 39.79% | 40.09% | - | 91.34% | 71.13% |
| D&A For EBITDA | 28.83 | 27.56 | 2.83 | 5.74 | 5.74 | 6.74 |
| EBIT | 191.67 | 132.57 | 16.32 | -0.04 | 1.44 | 1.1 |
| EBIT Margin | 31.31% | 32.94% | 34.17% | - | 18.32% | 9.99% |
| Effective Tax Rate | 26.63% | 25.58% | 24.44% | - | 26.90% | 25.17% |
| Revenue as Reported | 614.28 | 403.97 | 54.78 | 0 | 7.86 | 11.03 |
| Advertising Expenses | - | 2.26 | 0.54 | - | 0.15 | 1.2 |
Source: S&P Capital IQ. Standard template. Financial Sources.